4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-051148
10% owner sold 2,510 shares at $29.05 ($72,916)
From the SEC's structured data for this filing
Trades in this filing
UBS Oncology Impact Fund L.P. · 10% owner
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-11 | Sale : show line 1 in the form | −2,510 | $29.05 | $72,916 | 7,911,377 | D |
| Open-market sales · 2,510 sh · avg $29.05 · $72,916 | ||||||
Loading xslF345X03/doc4.xml…